Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Duchenne muscular dystrophy (DMD)
Biotech
Capricor shares turn red as FDA announces deramiocel adcomm plan
Capricor saw its shares fall 13% as the FDA plans to hold an advisory committee to review the company's DMD hopeful.
Ben Adams
May 6, 2025 8:32am
Entrada lays off 20% of staff weeks after having FDA hold lifted
Apr 30, 2025 4:38am
Wave's DMD drug remains on track in 48-week data
Mar 26, 2025 9:50am
Avidity's latest DMD data drop assuages safety concerns: analyst
Mar 17, 2025 2:00pm
PepGen pauses UK arm of DMD trial that's already on hold in US
Mar 4, 2025 10:25am
Entrada's 2-year ordeal ends as FDA lifts hold on DMD drug
Feb 24, 2025 11:08am
